Jumpcan Pharmaceutical adheres to the mission of "using technology to defend the health", devotes into building a big health undertaking, implements the quality concept of "quality first" and management philosophy of " three-zero" – "zero error in production management, zero defect in quality management, zero accident in safety management", and insists on the R & D concept of "leading the forefront, creating competitive products", vigorously developing the Chinese and western medicine and health care products and other new products to integrate both Chinese and Western medicine, having a product mix with 12 categories, more than 10 formulations and more than 210 strengths and specifications in detoxification category, digestive system, pediatric category, respiratory system category, nervous system category, anti-infection category, cardiovascular category, narcotic analgesic category, nutrition category, musculoskeletal category, hemostasis category and gynecology and so on, with more than 110 strengths and specifications included in the National Directory of Insured Drugs, more than 10 varieties being the exclusive varieties or exclusive formulations, and having formed five major preponderant fields - "pediatrics, gynecology, pneumology, gastroenterology and geriatrics, increasing its market competitiveness. The Chinese medicine product "Pudilan Anti-inflammatory Oral Liquid” won the Fourteenth Excellence National Patent Award and Excellent Quality Award; Xiao’er Chiqiao Qingre Keli won the Healthy China· pediatric drug most popular among parents; "Jinuo" and "tongxiao” won "excellent brand "award in digestive system category and pediatric category of Chinese chemical medicines.